Pharmacokinetic evaluation of toremifene and its clinical implications for the treatment of osteoporosis.

Expert opinion on drug metabolism & toxicology 20120401

Racial differences in bone mineral density and fractures in men receiving androgen deprivation therapy for prostate cancer.

The Journal of urology 20120301

Prognostic impact of the history of breast cancer and of hormone therapy in uterine carcinosarcoma.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20120201

MS2/TOF and LC-MS/TOF studies on toremifene to characterize its forced degradation products.

The Analyst 20111221

Anti-oestrogen therapy in the treatment of desmoid tumours: a systematic review.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20111201

Toremifene decreases vertebral fractures in men younger than 80 years receiving androgen deprivation therapy for prostate cancer.

The Journal of urology 20111201

[A case of an elderly breast cancer patient achieving partial response with toremifene without efficacy of letrozole as a preoperative primary endocrine therapy].

Gan to kagaku ryoho. Cancer & chemotherapy 20111201

Relevance of the selective oestrogen receptor modulators tamoxifen, toremifene and clomiphene in doping field: endogenous steroids urinary profile after multiple oral doses.

Steroids 20111101

[Determination of 6 antiestrogens in fish tissues by ultra performance liquid chromatography-tandem mass spectrometry].

Se pu = Chinese journal of chromatography 20111101

Drug interaction potential of toremifene and N-desmethyltoremifene with multiple cytochrome P450 isoforms.

Xenobiotica; the fate of foreign compounds in biological systems 20111001

[Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].

Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110901

Urinary excretion profiles of toremifene metabolites by liquid chromatography-mass spectrometry. Towards targeted analysis to relevant metabolites in doping control.

Analytical and bioanalytical chemistry 20110801

Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials.

Breast cancer research and treatment 20110801

Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor-positive breast cancer: the results of a 2-year multicenter open randomized study.

Breast cancer research and treatment 20110801

Factors associated with vertebral fractures in men treated with androgen deprivation therapy for prostate cancer.

The Journal of urology 20110801

Mass spectrometric characterization of urinary toremifene metabolites for doping control analyses.

Journal of chromatography. A 20110722

[A retrospective study of high-dose toremifene treatment for patients with aromatase inhibitor refractory advanced or metastatic hormone receptor-positive breast cancer].

Gan to kagaku ryoho. Cancer & chemotherapy 20110701

Re: Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer. M. R. Smith, R. A. Morton, K. G. Barnette, P. R. Sieber, S. B. Malkowicz, D. Rodriguez, M. L. Hancock and M. S. Steiner. J Urol 2010;184:1316-1321.

The Journal of urology 20110601

Mass spectrometric characterization of toremifene metabolites in human urine by liquid chromatography-tandem mass spectrometry with different scan modes.

The Analyst 20110207

Diethylenetriamine pentaacetic acid derivative of toremifene and in vitro evaluation in human breast cancer cell line MCF-7.

Cancer biotherapy & radiopharmaceuticals 20110201

Prostate cancer: Reducing fracture risk in men on androgen deprivation therapy.

Nature reviews. Urology 20110101

The effect of toremifene on lipid metabolism compared with that of tamoxifen in vitro.

Gynecologic and obstetric investigation 20110101

[A case of aromatase inhibitor-tolerant metastatic breast cancer revealing complete remission with high-dose toremifene therapy].

Gan to kagaku ryoho. Cancer & chemotherapy 20110101

Breast pain.

BMJ clinical evidence 20110101

Inhibition of FOSL1 overexpression in antiestrogen-resistant MCF-7 cells decreases cell growth and increases vacuolization and cell death.

Steroids 20110101

[The combined effect of Paclitaxel and toremifene therapy for estrogen receptor positive and aromatase inhibitor resistant metastatic breast cancer].

Gan to kagaku ryoho. Cancer & chemotherapy 20101101

Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor.

Breast cancer (Tokyo, Japan) 20101001

Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells.

Breast cancer research and treatment 20101001

Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer.

The Journal of urology 20101001

Androgen deprivation therapy in prostate cancer: anticipated side-effects and their management.

Current opinion in supportive and palliative care 20100901

Effects of toremifene and tamoxifen on lipid profiles in post-menopausal patients with early breast cancer: interim results from a Japanese phase III trial.

Japanese journal of clinical oncology 20100701

Uterine changes during tamoxifen, toremifene, and other therapy for breast cancer: evaluation with magnetic resonance imaging.

Japanese journal of radiology 20100701

Potential role of the steroid receptor pattern in the response of inoperable intra-abdominal desmoid to toremifene after failure of tamoxifen therapy.

International journal of colorectal disease 20100601

Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer.

Cancer 20100515

Synthesis, radiolabeling and In Vivo tissue distribution of an anti-oestrogen glucuronide compound, (99m)Tc-TOR-G.

Anticancer research 20100401

Toremifene use does not alter serum inhibin A and B levels during mid-luteal phase in women with premenstrual mastalgia.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20100201

Analysis of prognostic factors in male breast cancer: a report of 72 cases from a single institution.

Chinese journal of cancer 20100201

[Clinicopathological features of endometrial carcinoma in tamoxifen- and toremifene-treated breast cancer patients].

Gan to kagaku ryoho. Cancer & chemotherapy 20100201

[A case of recurrent breast cancer with extensive liver metastasis successfully treated with endocrine therapy].

Gan to kagaku ryoho. Cancer & chemotherapy 20091201

[A case of advanced breast cancer with multiple bone metastases responding to docetaxel and high-dose toremifene as fourth-line chemo-endocrine therapy].

Gan to kagaku ryoho. Cancer & chemotherapy 20091201

Synthesis of a novel antiestrogen radioligand (99mTc-TOR-DTPA).

Cancer biotherapy & radiopharmaceuticals 20091201

Breast magnetic resonance imaging findings in women treated with toremifene for premenstrual mastalgia.

Acta radiologica (Stockholm, Sweden : 1987) 20091101

[The combined effect of paclitaxel and toremifene therapy for metastatic breast cancer].

Gan to kagaku ryoho. Cancer & chemotherapy 20091101

[Efficacy and safety of high-dose toremifene for hormone-responsive advanced or metastatic breast cancer patients with failed prior treatment by aromatase inhibitors].

Gan to kagaku ryoho. Cancer & chemotherapy 20090901

Efficacy and tolerability of weekly paclitaxel in combination with high-dose toremifene citrate in patients with metastatic breast cancer.

Acta medica Okayama 20090801

Electrochemistry meets enzymes: instrumental on-line simulation of oxidative and conjugative metabolism reactions of toremifene.

Analytical and bioanalytical chemistry 20090701

[Efficacy of treatment with high-dose toremifene in patients with metastatic breast cancer resistant to aromatase inhibitor treatment].

Gan to kagaku ryoho. Cancer & chemotherapy 20090601

The effect of selective estrogen receptor modulator administration on the hypothalamic-pituitary-testicular axis in men with idiopathic oligozoospermia.

Fertility and sterility 20090401

Prostate cancer: a serious disease suitable for prevention.

BJU international 20090401

[A case of metastatic breast cancer resistant to anastrozole treatment responding to high-dose toremifene].

Gan to kagaku ryoho. Cancer & chemotherapy 20090401

Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group.

European journal of cancer (Oxford, England : 1990) 20090301

[Lipid metabolism disorders at the breast cancer patients receiving hormonotherapy].

Georgian medical news 20090301

Comparing the effects of atamestane, toremifene and tamoxifen alone and in combination, on bone, serum lipids and uterus in ovariectomized rats.

The Journal of steroid biochemistry and molecular biology 20090201

Pharmacokinetic analysis of a combined chemoendocrine treatment with paclitaxel and toremifene for metastatic breast cancer.

Breast cancer (Tokyo, Japan) 20090101

[On prevention and treatment of arterial hypertension in patients with breast cancer, and undergoing hormonotherapy].

Georgian medical news 20090101

Gene expression changes during the development of estrogen-independent and antiestrogen-resistant growth in breast cancer cell culture models.

Anti-cancer drugs 20090101

Effect of selective estrogen receptor modulators on cell proliferation and estrogen receptor activities in normal human prostate stromal and epithelial cells.

Prostate cancer and prostatic diseases 20090101

[A case of advanced breast cancer successfully treated with paclitaxel and toremifene therapy].

Gan to kagaku ryoho. Cancer & chemotherapy 20081101

[Recurrence of skin and lymph nodes from asynchronous breast cancer successfully treated with paclitaxel and toremifene therapy--a case report].

Gan to kagaku ryoho. Cancer & chemotherapy 20081101

Tamoxifen for salivary gland adenoid cystic carcinoma: report of two cases.

Journal of cancer research and clinical oncology 20081001

Clusterin: a potential target for improving response to antiestrogens.

International journal of oncology 20081001

Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20080901

Angiomyofibroblastoma of the vagina in a breast cancer patient.

Pathology 20080801

The use of radiation therapy after breast-conserving surgery in hormonally treated breast cancer patients is dependent on patient age, geographic region, and surgeon specialty.

American journal of surgery 20080601

Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer.

Endocrine-related cancer 20080601

Toremifene improves lipid profiles in men receiving androgen-deprivation therapy for prostate cancer: interim analysis of a multicenter phase III study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080410

[Effect of tetrandrine, toremifene and their combination on the reversion of multidrug resistance of K562/A02 cell line].

Zhongguo shi yan xue ye xue za zhi 20080201

Toremifene-atamestane; alone or in combination: predictions from the preclinical intratumoral aromatase model.

The Journal of steroid biochemistry and molecular biology 20080101

Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study.

The Journal of urology 20080101

A mass spectrometric approach for the study of the metabolism of clomiphene, tamoxifen and toremifene by liquid chromatography time-of-flight spectroscopy.

European journal of mass spectrometry (Chichester, England) 20080101

Effect of combined therapy with the antiestrogen agent toremifene and local hyperthermia on breast cancer cells implanted in nude mice.

Surgery today 20080101

Phase III, double-blind, controlled trial of atamestane plus toremifene compared with letrozole in postmenopausal women with advanced receptor-positive breast cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071101

The beneficial effects of toremifene administration on the hypothalamic-pituitary-testicular axis and sperm parameters in men with idiopathic oligozoospermia.

Fertility and sterility 20071001

Chemoprevention of prostate cancer: agents and study designs.

The Journal of urology 20070901

The effects of atamestane and toremifene alone and in combination compared with letrozole on bone, serum lipids and the uterus in an ovariectomized rat model.

Breast cancer research and treatment 20070701

[Evaluation of combination therapy of high-dose toremifene and oral chemotherapy].

Gan to kagaku ryoho. Cancer & chemotherapy 20070701

Relationship of cellular immunity, cytokines and CRP with clinical course in breast cancer patients with endocrine-dependent distant metastases treated with immunotherapy.

Cancer letters 20070628

Toremifene might improve side effects of ADT.

The Lancet. Oncology 20070401

Male breast cancer with mandibular metastasis. A case report.

Minerva stomatologica 20070401

[A patient with advanced recurrent breast cancer who firmly resisted hair loss and was then treated by combination therapy with high-dose toremifene and capecitabine].

Gan to kagaku ryoho. Cancer & chemotherapy 20070301

[A case of advanced breast cancer with multiple liver metastases resistant to chemotherapy responding to high-dose toremifene].

Gan to kagaku ryoho. Cancer & chemotherapy 20070301

DNA adduct formation in the livers of female Sprague-Dawley rats treated with toremifene or alpha-hydroxytoremifene.

Chemical research in toxicology 20070201

[A patient with advanced breast cancer refractory to chemotherapy accompanied by carcinomatous pleurisy and multiple bone metastasis that responded to combination therapy with high-dose toremifene and docetaxel].

Gan to kagaku ryoho. Cancer & chemotherapy 20070101

Effects of selective estrogen receptor modulators and genistein on the expression of ERalpha/beta and COX-1/2 in ovarectomized mouse uteri.

European journal of gynaecological oncology 20070101

Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs).

Current medicinal chemistry 20070101

Breast pain.

BMJ clinical evidence 20070101

The cardiovascular effects of selective estrogen receptor modulators.

Annals of the New York Academy of Sciences 20061201

Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial.

The Journal of urology 20060901

Determinants of early distant metastatic disease in elderly patients with breast cancer.

American journal of surgery 20060901

Experimental adenomyosis.

Best practice & research. Clinical obstetrics & gynaecology 20060801

Histopathology and histomorphometry of the urogenital tract in 15-month old male and female rats treated neonatally with SERMs and estrogens.

Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20060801

Selective estrogen receptor modulators (SERMS).

Arquivos brasileiros de endocrinologia e metabologia 20060801

Toremifene for premenstrual mastalgia: a randomised, placebo-controlled crossover study.

BJOG : an international journal of obstetrics and gynaecology 20060601

DNA damage and altered gene expression of enzymes for metabolism and DNA repair by tamoxifen and toremifene in the female rat liver.

Cancer science 20060601

Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Toremifene: an evaluation of its safety profile.

Breast (Edinburgh, Scotland) 20060401

Hepatocellular neoplasms after intrahepatic transplantation of ovarian fragments into ovariectomized rats.

Hepatology (Baltimore, Md.) 20060401

Toremifene--a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapy.

Expert opinion on investigational drugs 20060301

Absence of DNA adduct in the leukocytes from breast cancer patients treated with toremifene.

Chemical research in toxicology 20060301

Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells.

International journal of cancer 20060215

Adverse outcome and resistance to adjuvant antiestrogen therapy in node-positive postmenopausal breast cancer patients-The role of p53.

Breast (Edinburgh, Scotland) 20060201

Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.

Cancer 20060201

A double-blind randomized controlled trial of toremifen therapy for mastalgia.

Archives of surgery (Chicago, Ill. : 1960) 20060101

Mastalgia.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 20060101

Questioning the utility of pooling samples in microarray experiments with cell lines.

The International journal of biological markers 20060101

Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells.

Apoptosis : an international journal on programmed cell death 20051201

Bone mineral density and lipid changes during 5 years of follow-up in a study of prevention of breast cancer with toremifene in healthy, high-risk pre- and post-menopausal women.

Breast cancer research and treatment 20051001

[Experience of high-dose toremifene treatment for postmenopausal women with metastatic breast cancer].

Gan to kagaku ryoho. Cancer & chemotherapy 20051001

Stabilization and regression of a recurrent desmoid tumor with the antiestrogen toremifene.

Fertility and sterility 20050801

Beta-interferon and interleukin-2 prolong more than three times the survival of 26 consecutive endocrine dependent breast cancer patients with distant metastases: an exploratory trial.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20050601

A highly vascular intracranial solitary fibrous tumor treated with radiotherapy and toremifene: case report.

Neurosurgery 20050601

Endometrial K-ras mutations in postmenopausal breast cancer patients treated with adjuvant tamoxifen or toremifene.

Cancer chemotherapy and pharmacology 20050401

K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene.

British journal of cancer 20050328

Ovarian luteinized thecoma with sclerosing peritonitis in an adult woman treated with leuprolide and toremifene in complete remission at 5 years.

Gynecologic oncology 20050301

Role of 5a-reductase inhibitors and selective estrogen receptor modulators as potential chemopreventive agents for prostate cancer.

Clinical prostate cancer 20050301

Effects of neonatal exposure to diethylstilbestrol, tamoxifen, and toremifene on the BALB/c mouse mammary gland.

Biology of reproduction 20050201

[A patient with metastatic breast cancer associated with retention of pleural effusion with no response to both CMF and exemestane, whose life was saved by high-dose toremifene].

Gan to kagaku ryoho. Cancer & chemotherapy 20050201

Human desmoid fibroblasts: matrix metalloproteinases, their inhibitors and modulation by Toremifene.

BMC cancer 20050101

Treatment of Postmenopausal Breast Cancer with Selective Estrogen Receptor Modulators (SERMs).

Breast disease 20050101

Effect of anti-estrogens on the androgen receptor activity and cell proliferation in prostate cancer cells.

Urological research 20041201

Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93.

Annals of oncology : official journal of the European Society for Medical Oncology 20041201

Prospective evaluation of estrogen receptor-beta in predicting response to neoadjuvant antiestrogen therapy in elderly breast cancer patients.

Endocrine-related cancer 20041201

Effects of toremifene (TOR) and tamoxifen (TAM) on serum lipids in postmenopausal patients with breast cancer.

Breast cancer research and treatment 20041101

Crossover trial for lipid abnormality in postmenopausal breast cancer patients during selective estrogen receptor modulators (SERMs) administrations.

Breast cancer research and treatment 20041101

Toremifene citrate (Fareston).

Clinical journal of oncology nursing 20041001

[Activity of toremifene plus mitomycin, vindesin and cisplatin regimen in unresectable non-small cell lung cancer].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20040801

Changes in bone mineral density during and after 3 years' use of tamoxifen or toremifene.

Maturitas 20040715

[A case of breast cancer with multiple bone metastases demonstrating complete remission with high-dose toremifene therapy].

Gan to kagaku ryoho. Cancer & chemotherapy 20040601

Requirements for transcriptional regulation by the orphan nuclear receptor ERRgamma.

Molecular and cellular endocrinology 20040430

Primary toremifene treatment for elderly postmenopausal women with breast cancer.

Oncology reports 20040201

A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research 20040201

Antiangiogenic treatment of mesenteric desmoid tumors with toremifene and interferon alfa-2b: report of two cases.

Diseases of the colon and rectum 20040101

Toxicity of selected cationic drugs in retinoblastomal cultures and in cocultures of retinoblastomal and retinal pigment epithelial cell lines.

Neurochemical research 20040101

Differential effects of toremifene on doxorubicin, vinblastine and Tc-99m-sestamibi in P-glycoprotein-expressing breast and head and neck cancer cell lines.

Acta oncologica (Stockholm, Sweden) 20040101

Kinetic studies of the radical-scavenging activity of estrogens and antiestrogens.

Anticancer research 20040101

Matrix metalloproteinase-9 (MMP-9) immunoreactive protein has modest prognostic value in locally advanced breast carcinoma patients treated with an adjuvant antiestrogen therapy.

Anticancer research 20040101

Toremifene, a new agent for treatment of mastalgia: an open study.

International journal of fertility and women's medicine 20040101

Chronic effects of toremifene on the vasculature of menopause-induced rats.

Vascular pharmacology 20031201

Acute effects of toremifene on the vasculature of intact and menopause-induced rats.

Vascular pharmacology 20031101

Ocular side-effects in breast cancer patients treated with tamoxifen and toremifene: a randomized follow-up study.

Acta ophthalmologica Scandinavica 20031001

Kinetics of inhibition of glutamate uptake by antioestrogens.

Pharmacology & toxicology 20031001

Alpha-hydroxylation of tamoxifen and toremifene by human and rat cytochrome P450 3A subfamily enzymes.

Chemical research in toxicology 20030901

Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.

Chemical research in toxicology 20030701

[Hormone therapy, chemotherapy and immunotherapy in breast carcinoma. The best strategy for your patient].

MMW Fortschritte der Medizin 20030612

Phase IIA clinical trial to test the efficacy and safety of Toremifene in men with high-grade prostatic intraepithelial neoplasia.

Clinical prostate cancer 20030601

[Combined effects of toremifene and paclitaxel on human breast cancer cell lines].

Gan to kagaku ryoho. Cancer & chemotherapy 20030501

Update on the current use of hormonals as therapy in advanced breast cancer.

Anti-cancer drugs 20030401

Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030315

The effects of tamoxifen and toremifene on bone cells involve changes in plasma membrane ion conductance.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20030301

Down-regulation of nitric oxide production by droloxifene and toremifene in human breast cancer cells.

Oncology reports 20030101

[Perspectives for the hormonal therapy of breast cancer].

Magyar onkologia 20030101

Antiproliferative properties of toremifene on AIDS-related Kaposi's sarcoma cells.

Chemotherapy 20021201

[Combined chemoendocrine therapy using adriamycin, cyclophosphamide and high dose toremifene in patients with recurrent breast cancer].

Gan to kagaku ryoho. Cancer & chemotherapy 20021101

[A case of metastatic breast cancer responding to weekly paclitaxel and high-dose toremifene administrated alternately].

Gan to kagaku ryoho. Cancer & chemotherapy 20021101

[Synergistic effect of toremifene and cisplatin on human lung cancer cell line A549].

Zhonghua zhong liu za zhi [Chinese journal of oncology] 20021101

Glutamate uptake is inhibited by tamoxifen and toremifene in cultured retinal pigment epithelial cells.

Pharmacology & toxicology 20020901

Toremifene metabolism in rat, mouse and human liver microsomes: identification of alpha-hydroxytoremifene by LC-MS.

Biomedical chromatography : BMC 20020801

Estrogen and selective estrogen receptor modulator regulation of insulin-like growth factor binding protein 5 in the rat uterus.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20020801

Tamoxifen and toremifene treatment of breast cancer and risk of subsequent endometrial cancer: a population-based case-control study.

International journal of cancer 20020720

[Antiestrogen therapy in the treatment of breast neoplasms].

Minerva ginecologica 20020601

Inhibitory effects of toremifene on N-methyl-N-nitrosourea and estradiol-17beta-induced endometrial carcinogenesis in mice.

Japanese journal of cancer research : Gann 20020601

[Assessment of post-administration body distribution of toremifene and tamoxifen, and their administration regimens].

Gan to kagaku ryoho. Cancer & chemotherapy 20020601

Comparison of the effects of EM-652 (SCH57068), tamoxifen, toremifene, droloxifene, idoxifene, GW-5638 and raloxifene on the growth of human ZR-75-1 breast tumors in nude mice.

International journal of cancer 20020510

Tamoxifen and toremifene impair retrieval, but not acquisition, of spatial information processing in mice.

Pharmacology, biochemistry, and behavior 20020501

Activation of Maxi Cl(-) channels by antiestrogens and phenothiazines in NIH3T3 fibroblasts.

Steroids 20020501

Effects of transforming growth factor-beta1 and tumour necrosis factor-alpha on cultured fibroblasts from skin fibroma as modulated by toremifene.

International journal of cancer 20020420

Evaluation of the cytotoxicity of selected systemic and intravitreally dosed drugs in the cultures of human retinal pigment epithelial cell line and of pig primary retinal pigment epithelial cells.

Toxicology in vitro : an international journal published in association with BIBRA 20020401

99mTc-sestamibi imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20020401

Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model.

Cancer research 20020301

Tamoxifen and toremifene cause impairment of learning and memory function in mice.

Pharmacology, biochemistry, and behavior 20020101

[A case of locally recurrent breast cancer in which phlebothrombosis of the right leg after hormonal therapy using a high dose of toremifene citrate].

Gan to kagaku ryoho. Cancer & chemotherapy 20020101

Synergistic antitumour effect of a combination of toremifene and interferon-alpha on ZR-75-1 human breast cancer cells: dependence on interferon-alpha subtype.

Oncology reports 20020101

Toxicity of antiestrogens.

The breast journal 20020101

Selective estrogen receptor modulators as a new therapeutic drug group: concept to reality in a decade.

Clinical breast cancer 20020101

A phase II trial of interferon-alpha and toremifene in advanced renal cell cancer patients.

Cancer investigation 20020101

Breast-conservation treatment for bilateral breast cancer in five Japanese women.

Oncology reports 20020101

An elderly patient with DCIS of the breast effectively treated with toremifene alone.

Oncology reports 20020101

Evolving uses of hormonal agents for breast cancer therapy.

Clinical therapeutics 20020101

[Selective estrogen receptor modulators (SERMs) in the practice].

Magyar onkologia 20020101

Synthesis and reactivity of potential toxic metabolites of tamoxifen analogues: droloxifene and toremifene o-quinones.

Chemical research in toxicology 20011201

Synthesis and secretion of transforming growth factor-beta1 by human desmoid fibroblast cell line and its modulation by toremifene.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20011101

Okadaic acid-sensitive activation of Maxi Cl(-) channels by triphenylethylene antioestrogens in C1300 mouse neuroblastoma cells.

The Journal of physiology 20011001

GTx begins next phase of clinical trials for prostate cancer.

Expert review of anticancer therapy 20011001

Delayed effects of tamoxifen in hepatocarcinogenesis-resistant Fischer 344 rats as compared with susceptible strains.

Cancer letters 20010928

Comparisons of the effects of tamoxifen, toremifene and raloxifene on enzyme induction and gene expression in the ovariectomised rat uterus.

The Journal of endocrinology 20010901

[A case of breast cancer with bone marrow and liver metastases responding completely to low-dose weekly paclitaxel combined with toremifene].

Gan to kagaku ryoho. Cancer & chemotherapy 20010901

Adenomyosis--a result of disordered stromal differentiation.

The American journal of pathology 20010801

[Antiangiogenic and antimetastatic effects of toremifene citrate].

Gan to kagaku ryoho. Cancer & chemotherapy 20010801

Induction of atypical ductal hyperplasia in mouse mammary gland organ culture.

Journal of the National Cancer Institute 20010718

Cell-transforming activity and estrogenicity of bisphenol-A and 4 of its analogs in mammalian cells.

International journal of cancer 20010701

[Endocrine therapy for advanced or recurrent breast cancer].

Gan to kagaku ryoho. Cancer & chemotherapy 20010701

Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial.

Cancer chemotherapy and pharmacology 20010701

The antiestrogen toremifene protects against alcoholic liver injury in female rats.

Journal of hepatology 20010701

Phase II trial of toremifene in androgen-independent prostate cancer: a Penn cancer clinical trials group trial.

American journal of clinical oncology 20010601

[A case of breast cancer with multiple bone metastases improved by high-dose toremifene].

Gan to kagaku ryoho. Cancer & chemotherapy 20010601

Mechanism of lower genotoxicity of toremifene compared with tamoxifen.

Cancer research 20010515

Sex difference in alcohol-related organ injury.

Alcoholism, clinical and experimental research 20010501

Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women.

British journal of cancer 20010401

The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer.

British journal of cancer 20010401

3,3'-diindolylmethane, a major condensation product of indole-3-carbinol, is a potent estrogen in the rainbow trout.

Toxicology and applied pharmacology 20010201

[A case of lung and pleural metastases from breast cancer responding to toremifene].

Gan to kagaku ryoho. Cancer & chemotherapy 20010201

[A breast cancer patient with recurrence in the thoracic wall in whom a high-dose of toremifene was effective].

Gan to kagaku ryoho. Cancer & chemotherapy 20010201

Non-steroidal anti-oestrogens inhibit the differentiation of synovial macrophages into dendritic cells.

Rheumatology (Oxford, England) 20010201

Effect of the molecular weight of poly(epsilon-caprolactone-co-DL-lactide) on toremifene citrate release from copolymer/silica xerogel composites.

International journal of pharmaceutics 20010105

The phagocytosis of rod outer segments is inhibited by selected drugs in retinal pigment epithelial cell cultures.

Pharmacology & toxicology 20010101

Effects of acute and chronic body weight gain reductions in the evaluation of agents for efficacy in mammary cancer prevention.

Oncology reports 20010101

Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy.

Breast cancer research and treatment 20010101

Phase III randomized trial of toremifene vs tamoxifen in hormonodependant advanced breast cancer.

Breast cancer research and treatment 20010101

Cone voltage and collision cell collision-induced dissociation study of triphenylethylenes of pharmaceutical interest.

Rapid communications in mass spectrometry : RCM 20010101

Postoperative PINP in serum reflects metastatic potential and poor survival in node-positive breast cancer.

Anticancer research 20010101

Nuchal aggressive fibromatosis in childhood: two instructive case reports.

Clinical oncology (Royal College of Radiologists (Great Britain)) 20010101

Comparative tolerability of first-generation selective estrogen receptor modulators in breast cancer treatment and prevention.

Drug safety 20010101

[Antiestrogens: mechanism of action and clinical applications].

Salud publica de Mexico 20010101

Toremifene-induced fatty liver and NASH in breast cancer patients with breast-conservation treatment.

International journal of oncology 20001201

Comparison of the effects of tamoxifen and toremifene on rat hepatocarcinogenesis.

Archives of toxicology 20000701

Initiating activity of the anti-estrogen tamoxifen, but not toremifene in rat liver.

Carcinogenesis 19971101

A two-year dietary carcinogenicity study of the antiestrogen toremifene in Sprague-Dawley rats.

Drug and chemical toxicology 19961101

Comparison of the effects of tamoxifen and toremifene on liver and kidney tumor promotion in female rats.

Carcinogenesis 19951101

Peroxidase activation of tamoxifen and toremifene resulting in DNA damage and covalently bound protein adducts.

Carcinogenesis 19950301

Alterations of drug metabolizing and antioxidant enzyme activities during tamoxifen-induced hepatocarcinogenesis in the rat.

Carcinogenesis 19940501

Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats.

Cancer research 19931001

Toremifene enhances cell cycle block and growth inhibition by vinblastine in multidrug resistant human breast cancer cells.

Oncology research 19930101

Tamoxifen induces hepatocellular carcinoma in rat liver: a 1-year study with two antiestrogens.

Archives of toxicology 19930101